Clarithromycin, Sulfamethoxazole/Trimethoprim or Observation in Newly Diagnosed Multiple Myeloma
Status:
Unknown status
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
This study evaluates the effect of prophylactic antibiotics in multiple myeloma. One third of
patients will received treatment with clarithromycin, one third of patients will receive
treatment with sulfamethoxazole/trimethoprim and one third will be observed without
prophylactic antibiotics. All patients receive concurrent anti-myeloma treatment.
Phase:
Phase 2
Details
Lead Sponsor:
Henrik Gregersen
Collaborator:
Danish Myeloma Study Group
Treatments:
Clarithromycin Sulfamethoxazole Trimethoprim Trimethoprim, Sulfamethoxazole Drug Combination